The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trial
Anna Kopczak(Mayo Clinic), Martin Dichgans(Munich Cluster for Systems Neurology), Daniëlle Kerkhofs(Maastricht University), Maud van Dinther(Maastricht University Medical Centre), Fergus Doubal(University of Edinburgh), Peter M. Rothwell(UK Dementia Research Institute), Marie‐Germaine Bousser(Lund University), Geert Jan Biessels(University Medical Center Utrecht), Michael J. Thrippleton(MRC Centre for Regenerative Medicine), Martin Middeke(Technologie- und Förderzentrum im Kompetenzzentrum für Nachwachsende Rohstoffe), Elisabeth André(University of Augsburg), Ulrich Mansmann(Zimmer Biomet (Netherlands)), Julie Staals(Maastricht University), Bo Norrving(Lund University), Hilde van den Brink(University Medical Center Utrecht), Gordon W. Blair(University of Edinburgh), Michael Stringer(UK Dementia Research Institute), Alastair J.S. Webb(Imperial College London), Marco Duering(LMU Klinikum), Robert van Oostenbrugge(Maastricht University), Laurien Onkenhout(University Medical Center Utrecht), Karolina Wartolowska(John Radcliffe Hospital), Joanna M. Wardlaw(University of Edinburgh)
Cited by 13
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Small vessel disease: mechanisms and clinical implications
|The Lancet Neurology|2019|1.7k